Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rowa Bakadlag
Observed name:
Bakadlag, Rowa
Institutions:
Lady Davis Institute for Medical Research,
McGill University
Observed institutions:
Jewish General Hospital,
McGill University and Génome Québec Innovation Centre,
Collège MacDonald,
Lady Davis Institute for Medical Research,
McGill University
ORCID:
0000-0003-4221-3429
Observed ORCID:
0000-0003-4221-3429
OpenAlex ID:
A5067025865
Works
23
Awards
4
The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
2019
·
Rowa Bakadlag
, Pouria Jandaghi
, et al.
·
Expert Opinion on Therapeutic Targets
·
21
The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells
2023
·
Rowa Bakadlag
, Georgia Limniatis
, et al.
·
BMC Cancer
·
13
PDF
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
2024
·
Alexandre Benoit
, Madelyn J. Abraham
, et al.
·
International Journal of Hematology
·
9
PDF
Tungsten
2022
·
Koren K. Mann
, Rowa Bakadlag
, et al.
·
Elsevier eBooks
·
3
The role of tungsten in modulating DNA double-strand break repair and class switch recombination
2025
·
Rowa Bakadlag
, Hsiang Chou
, et al.
·
Toxicology and Applied Pharmacology
·
2
CRISPR screen uncovers SLC26A2 as a modulator of tungsten toxicity in endochondral ossification
2026
·
Rowa Bakadlag
, Sheena Li
, et al.
·
Environmental Research
The Mechanisms of Tungsten-induced Toxicity
2026
·
Bakadlag, Rowa
Show more works
View as search
Works count:
23
Citation count:
49
H-index:
3
I10-index:
2
Year
Topic
Type